Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Ovarian Neoplasms
10
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00001272
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
Completed · Phase 1
NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Completed · Phase 3
NCT00191646
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Completed · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Ovarian Neoplasms
🏥 Names
Disease Name
Ovarian Neoplasms
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Ovarian Neoplasms
topic type
disease
tcmsp disease id
598
🌿 Related Herbs
1 · contains this compound⚗️ Related Ingredients
4 · compounds in this herb🧬 Gene / Protein Targets
2 · genes implicated in this diseaseCytochrome P450 1A2
Glutathione S-transferase P
📋 Clinical Trials
10 · subject of clinical studyNCT00001272 A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Sti
→ Ovarian Neoplasms
NCT01015118 LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel an
→ Ovarian Neoplasms|Peritoneal Neoplasms
NCT00191646 An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That
→ Genital Neoplasms, Female|Fallopian Tube Neoplasms
NCT01462890 Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standar
→ Genital Diseases, Female|Ovarian Diseases|Ovarian
NCT01616303 A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemothera
→ Ovarian Neoplasms
NCT02429687 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
→ Ovarian Germ Cell Cancer|Ovarian Neoplasms|Ovarian
NCT02429700 TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
→ Ovarian Sex Cord Stromal Tumor|Ovarian Neoplasms|O
NCT03648489 Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube o
→ Ovarian Cancer|Ovarian Neoplasms|Ovarian Carcinosa
NCT04498117 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovari
→ Carcinoma, Ovarian Epithelial|Ovarian Neoplasms|Ov
NCT05185947 Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Perit
→ Gynecologic Cancer|Gynecologic Neoplasms|Peritonea
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables